Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation Complex Coronary Cases 2023

CCC2023 Cardiology Board Review 2023: Basic Concepts in Atherosclerosis

Presenter: Pedro R. Moreno

June 14, 2023

Presentation Controversies and Advances 2021

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Presenter: P. K. Shah

December 03, 2021

Presentation AHA 2019

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Presenter: Matthew Budoff

November 18, 2019

Presentation Controversies and Advances 2017

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Presenter: Sanjay Kaul

November 16, 2017

Presentation TCT 2017

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James E. Muller

November 01, 2017

Presentation TCT 2017

Potential Interventions for Hypertensive Patients With HFpEF

Presenter: Mark C. Bates, Bernard J. Gersh, William T. Abraham

October 30, 2017

Presentation TCT 2017

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation ACC 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Presentation TCT 2016

Anti-inflammatory Therapies for Atherosclerosis

Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif

October 30, 2016

Presentation

Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident MI in Patients Undergoing Elective Cardiac Evaluation

Presenter: J. Hartiala

August 03, 2016

Presentation Fellows 2016

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Kevin Croce

April 15, 2016

Presentation Fellows 2015

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Ajay J. Kirtane, Mauricio G. Cohen, Greg L. Kaluza

May 15, 2015

Presentation

ADAPT-DES Substudy: Effect of Obesity on Coronary Atherosclerosis and Outcomes of PCI

Presenter: S.J. Kang

January 20, 2015

Presentation Fellows 2013

Pathophysiology of Atherosclerosis and Vulnerable Plaque

Presenter: Greg Kaluza

April 15, 2013

Presentation TCT 2012

Angiographic progression of coronary atherosclerosis in Culprit and Non-culprit lesion

Presenter: Seung pyo Hong, Ja Young Son, Byung Kyu Kim, Byung Ho Kim, Young Soo Lee, Jin Bae Lee, Jae Kean Ryu, Ji Yong Choi, Sung Gug Chang, Kee Sik Kim

January 03, 2012

Advertisement

CCC2023 Cardiology Board Review 2023: Basic Concepts in Atherosclerosis

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Potential Interventions for Hypertensive Patients With HFpEF

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Why Are Hypertension and Coronary Artery Disease So Connected?

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Anti-inflammatory Therapies for Atherosclerosis

Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident MI in Patients Undergoing Elective Cardiac Evaluation

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

ADAPT-DES Substudy: Effect of Obesity on Coronary Atherosclerosis and Outcomes of PCI

Pathophysiology of Atherosclerosis and Vulnerable Plaque

Angiographic progression of coronary atherosclerosis in Culprit and Non-culprit lesion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content